Advertisement

Topics

Camurus Interim Report January-March 2019

07:19 EDT 9 May 2019 | FinanzNachrichten

STOCKHOLM, May 9, 2019 /PRNewswire/ -- "Initial sales of Buvidal follows plan and we are expecting to see significant growth during the year" Summary first quarter 2019 Buvidal launched as the fir...

Original Article: Camurus Interim Report January-March 2019

NEXT ARTICLE

More From BioPortfolio on "Camurus Interim Report January-March 2019"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...